Pregnancy Registry Among Adolescent Girls and Young Women in Rural KwaZulu-Natal, South Africa: STI-Associated Maternal and Neonatal Outcomes, 2022-2025.
South Africa, 2022 - 2025
Get Microdata
Reference ID
AHRI.FD01-01.Fertility.Dataset.v1
Producer(s)
Sweetness Dube, Nompumelelo Mkwanazi, Nqobile Ngoma, Prof. Maryam Shahmanesh, Thetha Nami Ngithethe Nawe Research Group, Data Management Team, KwaZulu-Natal Department of Health
Metadata
Created on
Aug 17, 2026
Last modified
Aug 17, 2026
- Data files
-
FD01-01
Fertility
Dataset v.1
STI Treatment Regimen (sti_treatment_regimen)
Data file: FD01-01 Fertility Dataset v.1
Overview
Valid:
9
Invalid:
51
Type:
Discrete
Decimal:
0
Width:
12
Range:
1 - 99
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | VDS treatment: Ceftriaxone IM + Doxycycline + Metronidazole | 1 |
11.1%
|
| 2 | GUS (genital ulcer) - HSV regimen: Acyclovir | 0 |
0%
|
| 3 | GUS (genital ulcer) - Syphilis regimen: Benzathine Penicillin | 1 |
11.1%
|
| 4 | Pelvic Inflammatory Disease/Lower Abdominal Pain Syndrome: Ceftriaxone IM + Doxycycline + Metronidazole | 0 |
0%
|
| 5 | Urethral discharge syndrome: Ceftriaxone IM + Doxycycline | 0 |
0%
|
| 6 | Trichomoniasis: Metronidazole | 0 |
0%
|
| 7 | Bacterial vaginosis: Metronidazole | 0 |
0%
|
| 8 | Candidiasis: Fluconazole | 0 |
0%
|
| 9 | Gonorrhoea (lab confirmed): Ceftriaxone IM | 0 |
0%
|
| 10 | Chlamydia (lab confirmed): Doxycycline | 0 |
0%
|
| 11 | Mixed infection treatment: As per clinical combination | 0 |
0%
|
| 12 | Partner treatment pack given | 0 |
0%
|
| 99 | Other regimen / not documented | 7 |
77.8%
|
| Sysmiss | 51 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.